Nuveen Asset Management, LLC Cytek Biosciences, Inc. Transaction History

Nuveen Asset Management, LLC

$329 Billion
Q1 2024

A detailed history of Nuveen Asset Management, LLC transactions in Cytek Biosciences, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 305,665 shares of CTKB stock, worth $1.71 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

305,665

Previous 317,746 3.8%

Holding current value

$1.71 Million

Previous $2.9 Million 29.2%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$6.29 - $9.15 $75,989 - $110,541	-12,081 Reduced 3.8%	305,665 $2.05 Million
Q4 2023 Feb 14, 2024	BUY	$4.1 - $9.51 $34,587 - $80,226	8,436 Added 2.73%	317,746 $2.9 Million
Q3 2023 Nov 14, 2023	SELL	$5.52 - $9.5 $353 - $608	-64 Reduced 0.02%	309,310 $1.71 Million
Q2 2023 Aug 14, 2023	SELL	$6.69 - $11.99 $4.18 Million - $7.49 Million	-625,087 Reduced 66.89%	309,374 $2.64 Million
Q1 2023 May 15, 2023	SELL	$8.44 - $13.47 $1.98 Million - $3.16 Million	-234,421 Reduced 20.06%	934,461 $8.59 Million

Q4 2022 Feb 14, 2023	SELL	$9.71 - $15.86 $1.66 Million - $2.71 Million	-171,042 Reduced 12.77%	1,168,882 $11.9 Million
Q3 2022 Nov 14, 2022	BUY	$10.96 - $15.45 $9.81 Million - $13.8 Million	895,330 Added 201.38%	1,339,924 $19.7 Million
Q2 2022 Aug 15, 2022	BUY	$7.41 - $11.56 $699,177 - $1.09 Million	94,356 Added 26.94%	444,594 $4.77 Million
Q1 2022 May 16, 2022	BUY	$9.89 - $17.25 $2.78 Million - $4.85 Million	281,263 Added 407.78%	350,238 $3.98 Million
Q4 2021 Feb 14, 2022	BUY	$16.14 - $25.04 $740,648 - $1.15 Million	45,889 Added 198.77%	68,975 $1.23 Million
Q3 2021 Nov 12, 2021	BUY	$17.52 - $27.93 $404,466 - $644,791	23,086 New	23,086 $494,000

Others Institutions Holding CTKB

# of Institutions

121

Shares Held

72.5M

Call Options Held

13.2K

Put Options Held

31.2K

View Full List

About Cytek Biosciences, Inc.

Ticker CTKB
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 134,627,008
Market Cap $754M
Description
Cytek Biosciences, Inc., a cell analysis solutions company, provides cell analysis tools that facilitates scientific advances in biomedical research and clinical applications. It offers aurora and northern lights systems, which are spectrum flow cytometers that delivers cell analysis by utilizing the fluorescence signatures from multiple lasers ...

More about CTKB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Cytek Biosciences, Inc. Transaction History